How might the MORPHO trial of gilteritinib impact clinical practice?

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/ac/db/b3/acdbb369-23a5-f4ef-1717-3b6405d74b6f/mza_5928252466954251512.jpeg/600x600bb.jpg

AML Hub

Scientific Education Support

29 episodes

1 week ago

The AML Hub is an open-access online resource dedicated to providing balanced, credible, and up-to-date medical education on acute myeloid leukemia (AML). Our aim is to enhance knowledge in AML through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management.

Hosted on Acast. See acast.com/privacy for more information.

Education

RSS

All content for AML Hub is the property of Scientific Education Support and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.